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Summary 
Background:  
Ultraviolet light decontamination systems are being used increasingly to supplement terminal 
disinfection of patient rooms. However efficacy may not be consistent in the presence of soil 
particularly against Clostridium difficile spores. 
Aim: 
To demonstrate in-use efficacy of two whole-room UV decontamination systems against 
three hospital pathogens with and without soil. 
 Methods:  
For each system, six patient rooms were decontaminated with UV-irradiation (enhanced-
disinfection) following manual terminal cleaning. Total aerobic colony counts of surface 
contamination were determined by spot-sampling 15 environmental sites before and after 
terminal disinfection and after UV-irradiation.  Efficacy against biological indicator coupons 
(stainless-steel discs) was performed for each system using test bacteria (106 cfu EMRSA-15 variant 
A, carbapenemase-producing K. pneumoniae) or spores (105  cfu C. difficile 027), incorporating low 
soiling (0.03% bovine serum albumin [BSA]), heavy soiling (10%BSA) or synthetic faeces (C. 
difficile  only) placed at five locations in the room.  
Findings:  
UV disinfection eliminated contamination after terminal cleaning in 8/14 (57%) and 11/14 
(79%) sites.    Both systems demonstrated 4 to 5 log10 reductions in MRSA and Klebsiella 
pneumoniae at low soiling. Lower and more variable log10 reductions were achieved when 
heavy soiling present. Between 0.1 and 4.8 log10 reductions in Clostridium difficile spores 
were achieved with low but not heavy soil challenge. 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
3 
 
 
 Conclusion:  
Terminal disinfection should be performed on all surfaces prior to UV decontamination. In-
house validation studies should be considered to ensure optimal positioning in each room 
layout and sufficient cycle duration to eliminate target pathogens.  
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Introduction  
Ultraviolet light decontamination systems are increasing in popularity as a means to remove 
Clostridium difficile spores and other pathogens from the hospital environment following 
terminal cleaning. Manual cleaning of surfaces is essential in reducing transmission but is 
labour intensive and open to user error despite use of biocidal/sporicidal agents. Areas missed 
during terminal cleaning continue to represent a risk of transmission. Using a UV fluorescent 
gel to demonstrate surfaces that have not been cleaned, compliance in a multicentre trial 
suggested cleaning compliance was only 49% (range 35%-81%).¹ Use of hypochlorite for 
terminal disinfection has been associated with reduction in incidence of Clostridium difficile 
infection in areas where the background incidence is high, although control of confounding 
factors are often inadequate.²  
 
There is accumulating evidence that C. difficile in the environment is responsible for hospital-
acquired cases of C. difficile infection in vulnerable patients.3 Although less effective than 
hydrogen peroxide vapour/aerosol systems, UV light decontamination systems are faster and 
less disruptive. Unlike hydrogen peroxide vapour disinfection, UV-C systems do not require 
changes to the heating, ventilation or air conditioning systems within the room.  The major 
disadvantage with all automated systems is that they cannot be used while the patient is in the 
bed area and their use is generally limited to supplement terminal disinfection of single 
rooms. Furthermore the positioning of the emitters is critical to the level of coverage of the 
environment i.e. area without shadows. UV-C systems do not replace terminal cleaning but a 
high level of disinfection can be achieved more easily than by manual cleaning.2  
 
In this study the efficacy of two UV-irradiation disinfection devices with different patterns of 
arrangement and number of emitters were compared in the clinical environment against 
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surface contamination and validated against in-house biological indicator organisms (C. 
difficile spores, Klebsiella pneumoniae, MRSA) in the presence of a high/low organic soil 
challenge.  
 
Methods  
For each test system, six patient single-isolation-rooms of similar size and layout were selected at a 
London teaching hospital. Each room was decontaminated prior to any efficacy testing following the 
hospital protocol (manual cleaning with ~1000ppm concentration peracetic acid solution; Diff-X, 
MTP Innovations, UK). As part of routine hospital practice, there was monitoring of the quality of 
terminal cleaning by domestic supervisors in a sample of rooms using ATP bioluminescence.4 
However, the cleaners were not aware of the sampling sites and no additional training was provided 
during the study. Sampling was performed immediately after terminal cleaning and was followed 
without delay by the setting up and use of the UV devices.   
 Ten microlitre aliquots of test bacteria (~106 cfu EMRSA-15 variant A, non-metallo-
carbapenemase-producing K. pneumoniae ST-258 (typed at AMRHAI Colindale UK ) or 
spores (105 cfu C. difficile 027 spores), prepared in low soiling (0.03% BSA), heavy soiling 
(10% BSA) or synthetic faeces (C. difficile 027 spores only) were inoculated onto 1cm2 
biological-indicator coupons (stainless-steel discs) and placed at various locations (1-Floor, 
2-Under bed, 3-Footrail, 4-Headboard, 5-bedside table) in the room. During UV disinfection 
the rooms were sealed and air changes maintained in a steady state (8 air changes/h). 
Enhanced cleaning/disinfection (UV-irradiation) of the room was performed using one of two 
devices:  
 
 A: Surfacide® Helios ™: a triple-emitter system (UVC, λ=254nm) arranged around the bed 
in triangular formation (medium setting). The emitters have a built-in laser mapping system 
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to scan the dimensions of the room and calculate the duration of the prescribed disinfection 
cycle. 
 
 B: Hygiene Solutions Ultra-V™: a single-emitter device (UVC, λ=265nm) relocated 
intermittently as determined by sensors in room. Sensor-units were positioned around the 
room to measure the dose of UV-energy received allowing the operator to deliver a 
minimum-required dose of irradiation. 
Biological indicator coupons were assayed to quantify bacterial/spore numbers and compared 
against numbers obtained from a control array (non-exposed BI coupons). For each UV-
decontamination system, all six test-rooms were evaluated pre and post-UV disinfection by 
spot-sampling. Three of the rooms were evaluated for efficacy using in-house biological-
indicator coupons. Total aerobic colony counts of surface contamination were measured in 
six rooms by spot-sampling up to 15 environmental sites before and after terminal 
disinfection and after UV-irradiation.  Surface swabs were taken using tryptone-soya agar 
contact plates (25cm2; Oxoid, UK) incorporating a neutralising solution (to quench residual 
disinfectant activity). 
 
Microbiological assessment for efficacy using in-house Biological Indicators  
Bacteria were grown aerobically in 10ml nutrient broth (Oxoid, UK) at 37°C for 18 
hours.  Cultures were centrifuged at 1500 x g for 10 minutes and resuspended in 10ml sterile 
bovine serum albumin (BSA; Sigma Aldrich, UK) at low (0.03% w/v) or heavy soil (10% 
w/v) concentrations.  C. difficile spore suspensions were prepared to a titre of 106 CFU/ml in 
10ml as described previously.5   Stock spore suspensions were centrifuged and resuspended in 
1ml BSA (0.03%) to represent low soiling or 1ml synthetic faeces (5% [w/v] tryptone, 5% 
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[w/v] BSA, 0.4% mucin [w/v] in phosphate buffered saline [PBS]) to represent heavy 
soiling.   
Ten µl of bacterial (~106 cfu) or spore suspension (~105 cfu) prepared in an organic soil were 
inoculated onto stainless steel coupons (n=3) and placed on a microplate lid. Microplates 
containing the biological indicator coupons were replicated equally six times (including 
control plate) and placed in various locations in the test side-room at pre-selected sites. 
Coupons were used within 30 minutes of inoculation. Test microplates were exposed to a full 
cycle of the test UV-decontamination system in accordance with manufacturers’ instructions 
on time and positioning of emitters. Control (unexposed) sets of microplates were placed in 
the rooms during cycles and each control microplate sealed with Parafilm™ tape and 
wrapped with 3 layers of aluminium foil (to shield from UV-irradiation).  
 
After testing, coupons were aseptically transferred to tubes containing either 10ml 
(unexposed control coupons) or 1ml (exposed test coupons) PBS.  Approximately 5 sterilised 
glass beads were added to each tube and samples were vortexed for 30 seconds.  Resulting 
suspensions were diluted in PBS and plated onto Columbia blood agar (Oxoid, UK) or 
Braziers C. difficile agar (Oxoid, UK).  Plates were incubated aerobically at 37°C for 24 
hours for bacteria and anaerobically at 37°C for 48 hours for C. difficile spores. 
Two-tailed tests were used for all analyses and differences were considered statistically 
significant when P<0.05. Log10 reduction = Log10(A) – Log10(B), where A and B are the 
numbers (cfu) before and after UV disinfection respectively. 
The study was considered to be service evaluation and ineligible for Research Ethics 
submission by UCL/UCLH Joint Research Office. 
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Results 
 All rooms selected were of similar size and included a dedicated en-suite bathroom.  
Terminal cleaning of the room and bathroom ranged between 95min ±35min (system A) and 
81min ±34min (system B) (Table I). Additional time incurred by supplementing terminal 
disinfection with enhanced (UV) disinfection was similar between the two systems when 
completing a full cycle in the room and a further cycle in the bathroom.  
 
Environmental contamination  
All (14/14) environmental sites were contaminated before terminal disinfection in both arms 
of the study (Table II). Contamination was highest on the floor areas of the room and patient 
en-suite bathroom and high-frequency touch areas (foot rail, bed-control panel, nurse-call 
button, bedside table, chair arm). Terminal disinfection was often ineffective in reducing 
contamination including near-patient surfaces. UV disinfection eliminated contamination in 
8/14 (57%) and 11/14 (79%) sites using systems A and B respectively. Sampling of C. 
difficile in the patient environment showed median 1 cfu pre terminal clean, pre UV clean and 
median 0 post UV clean on the toilet floor for both systems.     
 
Efficacy against biological indicator coupons  
Both systems demonstrated between 4 and 5 log10 reductions in MRSA and K. pneumoniae at 
low soiling (Table III). Lower and more variable log10 reductions were found at heavy 
soiling. 0.5 to 2.5 log10 reductions in Clostridium difficile with low soiling were achieved on 
floor surfaces, and for one system the bedside table, but not when heavy soil (synthetic 
faeces) was present.  
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Discussion  
Efficacy of ultraviolet-C light (wavelength: 100-280 nm) disinfection systems depends on 
intensity of the radiation, cycle duration, position of the emitter, presence of physical barriers 
and air movement. As radiation is subject to inverse square reduction with distance from the 
source and some surfaces such as glass do not reflect light efficiently, repeated cycles at 
different positions are often recommended to achieve a dose sufficient to reduce 
contaminating organisms to low levels. Various solutions are offered, for example, one 
system monitors the reflected light (254nM) and stops the cycle when the target level 
(reflected dose of 36000µWs/cm2) is reached. Spores are reduced by 2-4 log10 on surfaces in 
direct line of sight but less elsewhere.6  
 
Disinfection using UV irradiation is significantly less effective than hydrogen peroxide 
vapour, which achieves a 6 log10 reduction against C. difficile spores.7 The presence of a 
heavy soil challenge on the surface to be disinfected can attenuate bactericidal activity. Hence 
it is important the environment has been adequately decontaminated of dirt and debris during 
terminal cleaning. Nevertheless, there is evidence that use of UV-C disinfection of the patient 
environment is effective in reducing healthcare-acquired infection.  Use of portable pulsed 
xenon devices in single rooms after discharge of the patient were proposed to have been 
responsible for a reduction of hospital-acquired C. difficile infection from 9.46/105 patient 
days to 4.45/105 patient-days (p<0.01) in a retrospective study.8  The study also associated 
the implementation of UV-C disinfection with a fall in the numbers of  colectomies.  Another 
retrospective study suggested a 20% reduction in all hospital-acquired infection during a 22 
month period.9   However, there may have been confounding factors in either study.  In an 
interrupted time series, the use of ultraviolet irradiation to decontaminate single-isolation 
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rooms after discharge of the patient was associated with a fall in incidence of C. difficile 
infections compared with a rise where it was not used.10  A non-randomized study showed an 
additional 5% fall in C. difficile infections when UV disinfection was added to a package of 
measures.11 Finally a recent cluster-randomised study compared the use of combinations of 
quaternary ammonium disinfection, bleach and UV-C on acquisition and infection rates of 
MRSA, vancomycin-resistant enterococci, C. difficile and Acinetobacter.3   The overall 
incidence of these pathogens in patients next occupying the rooms was reduced when UV-C 
was added to standard cleaning. However, the incidence of C. difficile was not reduced by 
adding UV to bleach.  
 
The efficacy of UV disinfection is dependent on the presence of shadowing and the number 
of cycles used for the size of the room. Unlike biocidal efficacy testing, no test criteria 
stipulating reduction thresholds exist for the validation of UV-irradiation systems proposed 
for whole-room disinfection of the patient environment. Reduction thresholds should reflect 
the likely level of bacterial contamination on surfaces after terminal cleaning. Previous 
assessments of the clinical environment identified C. difficile bioburden on surfaces in the 
order of ~1 log10 cfu/cm2 in both high and low-frequency touch sites.5    
 
In the current study, enhanced disinfection using UV light was effective against MRSA and 
K. pneumoniae and reduced contamination from surfaces in the patient room missed during 
terminal cleaning. The most important factor affecting efficacy was the positioning of the 
emitters according to the size and arrangement of the room, accounting for the differences 
between systems (Table III). Despite variations in reduction with high inocula on coupons, 
both systems achieved reductions in bacterial numbers in the environment with low soil 
sufficient to prevent further transmission. C. difficile spores were more difficult to eradicate. 
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In a comparison of two other UV systems, they were equally effective against C difficile, 
VRE and MRSA but C difficile spores required 40 minute exposure for 3-log10 kill compared 
with 10 minutes for other pathogens.12   UV cycle durations should therefore be increased in 
rooms exposed to or at risk of C. difficile contamination.  
 
Conclusions 
In the absence of efficacy testing criteria for the validation of UV-irradiation devices, 
thresholds for reductions of contaminating bacteria and spores should be appropriate for 
levels representative of the setting. Careful positioning of the devices was effective in 
preventing shadowed areas. However when introducing a new system, in-house validation 
studies should be considered to ensure optimal positioning in each type of room layout and a 
sufficient cycle duration used to eliminate pathogens. Thresholds for reductions of 
contaminating bacteria should reflect the anticipated numbers in the environment after 
terminal cleaning. 
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Table I. Turnaround and duration of individual decontamination processes during 
terminal cleaning and UV-disinfection using the Surfacide® Helios and Ultra-V™ 
system (systems A and B respectively). 
Phase of decontamination 
episode 
Time required system A  
Mean (±SD) 
minutes 
Time required system B  
Mean (±SD) 
minutes 
  
Duration for domestic team 
to attend 59 (±33) 48 (±32) 
Terminal clean cycle 95 (±35)  81 (±34) 
Time to set up UV-device1 20 (±6) 28 (±6) 
UV-disinfection cycle 42 (±11) 36 (±6) 
Time to vacate (post UV-
cycle)2 7 (±5) 5 (±3) 
Total: Decontamination 
without UV 154 (±33) 120 (±12) 
Total: Decontamination 
including UV-disinfection 215 (±33) 199 (±17) 
1
 – Includes transport of equipment to the site and set-up/ arrangement of the UV system 
2
 – Time required removing all UV equipment and returning room to original state for patient 
accommodation. 
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Table II. Efficacy of System A (Surfacide® Helios) and System B (Ultra-V™) UV disinfection system against surface contamination in the patient 
environment (n=6) (aerobic colony count per 100 cm²) (IQR = interquartile range) 
 
 
 Environmental Surface Contamination (Aerobic colony counts) / 100cm2 
  Cleaning Phase  Pre-terminal clean  Pre-UV  Post-UV  
# Sample 
point 
System Description  Median  IQR  Median  IQR  Median  IQR  
1  A Floor corner  1048  920-3056  7040  5280-7776  28  24-52  
 B  936  324-1768  2944  2400-3200  64  28-108  
2  A Foot rail  120 108-276  4  0-4  0  0-0.8  
 B  208  140-272  32  16-60  2  0-4  
3  A Bed control panel  72  40-100  0  0-40  8  0-12  
 B  236  88-300  40  4-88  0  0-4  
4a  A Nurse call button (front)  184  100-516  40  0-92  0  0-0.8  
 B  328  196-724  4  0-28  0  0-8  
4b  A Nurse call button (back)  112  40-476  24 8-204  0  0-0  
 B  216  144-920  4  1-40  0  0-8  
5  A Bedside table  84  52-104  20  12-24  0  0-0  
 B  88  44-280  8  0-8  0  0-8  
6  A Chair arm  88  44-184  12  4-20 4  0-0  
 B  220  124-272  20  8-36  0  0-0  
7  A Bin lid  132  108-152  28  20-32 0  0-4  
 B  236  144-264  20  12-24  0  0-4  
8  A Inside door handle  44  8-80  4  0-8  4  0-4  
 B  68  36-120  8  4-12  0  0-4  
9  A Outside door handle * 22 20-28  8  0-20  88  24-160  
 B  76  48-180  20  4-68  88  68-136  
10  A Toilet floor  1360 920-2652  2016  1648-6000  196  160-200  
 B  1680  708-3120  3072  2208-4472  68  48-92  
11  A Toilet assist bar  4  0.8-24  0  0-8  0  0-0  
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 B  16  4-32  0  0-24  0  0-0  
12  A Toilet flush  84  20-204  0  0-8  0  0-0  
  B  84  40-120  8  4-12  0  0-0  
13  A Toilet seat  148  36-360  4  4-8  4  0-12  
 B  180  64-280  24  8-40 0  0-0  
14  A Shower handle  148  44-268  4  0.8-16  4  0.8-8  
 B  248  76-424  4  0-8  0  0-0  
 
*Not included in UV irradiation 
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Table III. Efficacy of UV disinfection against bacterial number on biological indicator coupon in median log10 reduction colony forming units. 
Reductions (Log10 CFUs) in biological indicator test organisms 
Sites MRSA Klebsiella pneumoniae Clostridium difficile 
 Low soil 
0.03% BSA 
Heavy soil 
10% BSA 
Low soil 
0.03% BSA 
Heavy soil 
10% BSA 
Low soil 
0.03% BSA 
Heavy soil 
Synthetic faeces 
System A       
Floor corner 4.9 4.5 6.3 5.7 2.5 0.5 
Floor under bed 5.5 4.5 5.2 5.7 2.1 0.6 
Foot rail 4.9 5.0 6.3 5.0 1.9 0.4 
Headboard 5.3 4.4 6.3 4.7 1.2 0.3 
Bedside Table 5.1 5.1 6.3 6.3 4.8 1.0 
       
System B       
Floor corner 3.9 2.3 4.2 1.4 0.3 <0.1 
Floor under bed 4.5 2.2 5.6 2.5 1.1 <0.1 
Foot rail 4.5 3.7 4.5 3.5 0.7 <0.1 
Headboard 3.9 3.6 3.9 1.0 0.7 <0.1 
Bedside Table 4.1 2.4 3.9 3.1 0.1 <0.1 
 
